UA90903U - Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension - Google Patents

Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension

Info

Publication number
UA90903U
UA90903U UAU201400891U UAU201400891U UA90903U UA 90903 U UA90903 U UA 90903U UA U201400891 U UAU201400891 U UA U201400891U UA U201400891 U UAU201400891 U UA U201400891U UA 90903 U UA90903 U UA 90903U
Authority
UA
Ukraine
Prior art keywords
lisinium
irbesartan
effectiveness
combination
evaluation
Prior art date
Application number
UAU201400891U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олена Олександрівна Нагорна
Тетяна Семенівна Брюзгіна
Надія Олександрівна Горчакова
Іван Сергійович Чекман
Original Assignee
Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. Богомольця filed Critical Національний Медичний Університет Імені О.О. Богомольця
Priority to UAU201400891U priority Critical patent/UA90903U/en
Publication of UA90903U publication Critical patent/UA90903U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed is a method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension through blood investigation. The fatty acid composition of lipids of blood plasma of hypertensive rats is determined by means of gas-liquid chromatography, with reveal of changes of content of palmitic, arachidonic fatty acids and the sums of saturated and polyunsaturated fatt acids before and after treatment with irbesartan in combination with lisinium during two months. The data are compared to control, and at normalization of induces the effectiveness of treatment is estimated.
UAU201400891U 2014-01-31 2014-01-31 Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension UA90903U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201400891U UA90903U (en) 2014-01-31 2014-01-31 Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201400891U UA90903U (en) 2014-01-31 2014-01-31 Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension

Publications (1)

Publication Number Publication Date
UA90903U true UA90903U (en) 2014-06-10

Family

ID=56283643

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201400891U UA90903U (en) 2014-01-31 2014-01-31 Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension

Country Status (1)

Country Link
UA (1) UA90903U (en)

Similar Documents

Publication Publication Date Title
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
EA201600471A1 (en) EXTRACTED VEGETABLE LIPID, CONTAINING LONG-SECONDENCY POLYNESATURATED FATTY ACIDS
BR112015005369A2 (en) usp30 inhibitors and methods for their use
SG10201803827UA (en) Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
CY1123942T1 (en) OMEGA-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISEASES CAUSING DAMAGE TO THE NERVOUS SYSTEM
MX2016017097A (en) Biomarkers for response to ezh2 inhibitors.
EP3037543A4 (en) Method for generating oil/fat component, method for producing higher unsaturated fatty acid, and chlamydomonas species strain jsc4
BR112014017048A8 (en) organic emulsion comprising dha and epa
UA90903U (en) Method for evaluation of effectiveness of use of irbesartan in combination with lisinium at experimental arterial hypertension
BR112016028561A8 (en) composition and dosage form comprising a marine oil comprising fatty acids, and use thereof
UA90901U (en) Method for evaluation of effectiveness of use of quinapril in combination with lisinium at experimental arterial hypertension
UA86387U (en) Method for evaluation of effectiveness of treatment of patients with arterial hypertension combined with metabolic syndrome
UA93021U (en) METHOD FOR EVALUATIon of EFFICIENCY OF CORRECTION of doxorubicin toxic effect in EXPERIMENT
UA106430U (en) Method for assessing impact of certain antioxidants on lipid fatty acid formula in tissues of experimental rats
UA75395U (en) Method for evaluation of effectiveness of application of anti-hypertensive preparations at arterial hypertension
UA67088U (en) Method for evaluation of effectiveness of use of bisoprol at arterial hypertension
UA82299U (en) Method for determination of fat acid composition of lipids of dandelion and chicory
UA67085U (en) Method for evaluation of effectiveness of use of amplodipin at arterial hypertension
UA92943U (en) METHOD FOR estimation of EFFICIENCY OF CORRECTION of lipid disorders in rat erythrocytes at cORAZOL MODEL of convulsion syndrome
UA92944U (en) METHOD for estimation of toxic effect of doxorubicin and its prevention in experiment
UA105585U (en) Method the estimation of fatty acid composition of common hazel pollen lipids
UA108535U (en) ALIMENTARY METHOD OF PREVENTION AND TREATMENT OF DYSBIOTIC DISEASES
UA90907U (en) Method for estimating deterioration of state of health in junior schoolchildren
BR112017002474A2 (en) fatty acid and palmitoylethanolamide mixture for use in the treatment of allergic and inflammatory conditions
UA67084U (en) Method for evaluation of effectiveness of application of combined therapy at arterial hypertension